Limited-Time September Offer: Try 7 Days for Free

Royalty Pharma (RPRX) Stock Price

$36.36 0%

Sign up
to add to portfolio

AI Score

  • Alternative

    7
  • Fundamental

    4
  • Technical

    6

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.

Sign up to get access to more historical data and insights on Royalty Pharma, AI stock picks, stock alerts and much more.

Sign up

RPRX AI Stock Analysis

AI stock analysis for RPRX is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Royalty Pharma (RPRX) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Royalty Pharma (RPRX) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Royalty Pharma (RPRX), currently trading at $36.36, will... Sign up to access price prediction.

About RPRX

LSE
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States.

  • Symbol

    RPRX

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    15.7B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$19.97
1.4%
8
INO Inovio Pharmaceuticals
INO
$2.38
10.2%
2
MRNA Moderna
MRNA
$23.51
7.4%
4
AVXL Anavex Life Sciences
AVXL
$9.37
2.2%
5
BBIO BridgeBio Pharma
BBIO
$51.21
2.6%
6

RPRX Alternative Data

Web Traffic

Royalty Pharma receives an estimated 13826 monthly visitors to royaltypharma.com, which is down by -1.5% over the last month.

  • Web Traffic

    13826

  • Change from Previous Month

    1.5%

  • 3 Month Change

    44.2%

  • YoY Change

    44.2%

LinkedIn Followers

7,924 are following Royalty Pharma on LinkedIn, up by 4.2% over the last month.

  • LinkedIn Followers

    7924

  • Daily Change

    0.1%

  • 1 Month Change

    4.2%

  • 3 Month Change

    8.3%

  • YoY Change

    8.3%

Job Postings

Royalty Pharma currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Royalty Pharma has 104 employees, down by -2.8% over the last month.

  • LinkedIn Employees

    104

  • Daily Change

    1%

  • 1 Month Change

    2.8%

  • 3 Month Change

    2%

  • YoY Change

    2%

Reddit Mentions

Royalty Pharma has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

News Mentions

Royalty Pharma was mentioned 5 times in the news yesterday.

  • News Mentions

    5

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

RPRX Financials

RPRX Key Metrics
  • Total Revenue

    $594M

  • Net Income

    $208M

  • Earnings per Share

    $0.46

  • Free cash flow

    $743M

  • EBITDA

    $362M

  • EBITDA Ratio

    0.609428

  • Total Assets

    $18.2B

RPRX 2-year Revenue & Income
RPRX 2-year Free Cash Flow

RPRX Technicals

RPRX SMA
RPRX RSI

FAQ

What's the current price of Royalty Pharma (RPRX) Stock?
The price of an Royalty Pharma (RPRX) share is $36.36.

What's the market cap of Royalty Pharma?
The current market cap of Royalty Pharma is 15.7B.

What are some stocks similar to Royalty Pharma (RPRX) that investors often compare it to?
Royalty Pharma (RPRX) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Royalty Pharma's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Royalty Pharma's stock price to be around $37.23 in 2026. Starting from the current price of $36.36, this represents a 2.4% change in price, indicating a neutral outlook for the stock.

How to buy Royalty Pharma (RPRX) Stock?
Royalty Pharma stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Royalty Pharma shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.